INSIGHTS ON UPSTREAM MANUFACTURING
-
Behind The Data: Engineering Hepatocyte-Targeted LNPs
See how lipid nanoparticle platforms can deliver RNA and large DNA payloads to primary human T cells, improving transfection, expression durability, and CAR insertion efficiency.
-
Behind The Data: Comprehensive Off-Target Assessment Strategies
Explore how biochemical, computational, and cell-based methods can identify, confirm, and interpret off-target editing risks, providing a more complete safety assessment for CRISPR-based therapeutics.
-
A Novel Non-Viral Platform For High-Efficiency T-Cell Engineering
Gain insight into how nuclease format, delivery method, and DNA template design influence knockout efficiency, targeted TCR integration, cell viability, and recovery.
-
Discovery And Validation Of High-Efficiency Large Serine Recombinases
Novel large serine recombinases demonstrate efficient targeted gene insertion across mammalian cell types. Learn how bioinformatic discovery can expand the toolkit for delivering large payloads.
-
Discovery And Validation Of Novel Large Serine Recombinases9/22/2026
Discover how bioinformatics, machine learning, and protein engineering can advance programmable gene insertion, with novel recombinases demonstrating strong mammalian-cell activity.
-
Why Isn't One Assay Enough For Gene Editing Off-Target Safety Assessment?9/22/2026
Gene editing off-target risk cannot be captured by one assay. Combining biochemical, computational, and cell-based methods with deep sequencing provides a more complete view of potential edits.
-
Challenges And Opportunities For MSC Expansion Workflows9/22/2026
Discover how optimizing cell culture platforms and closed systems reduces manufacturing costs, improves media efficiency, and supports scalable stem cell production.
-
Improving Scale-Up Starts With Expression Strategy9/21/2026
Early expression screening and strain-engineering strategies can reveal manufacturing risks and clarify which recombinant protein candidates are worth advancing before major investments are made.
UPSTREAM MANUFACTURING SOLUTIONS
-
Rushing early development without planning for commercialization can lead to delays. Aligning process and analytical strategies from the start supports efficient scale-up and smoother manufacturing.
-
A stable producer cell line platform designed to replace transient transfection in AAV manufacturing, offering 10 to 15-fold titer improvements and simplified workflows from development through commercial scale.
-
Used 500 liter Cytiva XDR-500 bioreactor system, model XDR-500. Includes (2) Rosemount Analytical model 1056 dual channel intelligent transmitters and (4) peristaltic pump heads, serial# XDR-08825-001, built 2011.
-
Used 500 liter Sartorius Biostat CultiBag single use bioreactor, model STR 500 DW, stainless steel bag holder with agitator drive, jacketed for 1 bar, control system with hmi touch screen, serial# STR-0550, built 2016.
-
Used lot of (2) 10 liter GE Xcellerex (Cytiva) single-use stirred tank bioreactors, model XDR-10. Includes Emerson model 1056 controllers and Mettler Toledo model PBA655-B60 20" x 16" platform scales, serial# 29188443 & 29188442, built 2016.